Danielle LaGrave, MS, LCGC

Phone: 800-242-2787, ext. 2020

Specialties

• Genetics, Constitutional FISH, Cytogenetics, Genomic SNP Microarray, NIPT, Maternal Serum Screening

Education

• Master’s Degree—Genetic Counseling, California State University, Northridge

Certification/Affiliations

• American Board of Genetic Counseling
• American College of Medical Genetics and Genomics
• National Society of Genetic Counselors
• American Society of Human Genetics

Research Interests

• Cell-free DNA
• Cytogenomic microarray

Recent Publications

• Herriges JC, et al. Delineating the clinical spectrum associated with Xq25q26.2 duplications: report of 2 families and review of the literature. J Child Neurol. 2019 Feb;34(2):86–93.
• Bhat G, et al. Xq11.1-11.2 deletion involving ARHGEF9 in a girl with autism spectrum disorder. Eur J Med Genet. 2016 Sep;59(9):470–3.
• Walker BS, et al. A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome. Prenat Diagn. 2015 May;35(5):440–6.
• Miller CE, et al. Genetic counselor review of genetic test orders in a reference laboratory reduces unnecessary testing. Am J Med Genet A. 2014;164A(5):1094–101.
• LaGrave D, Redman J. Laboratory infrastructure. In: Goodenberger ML, Thomas BC, Kruisselbrink T, eds. Practical Genetic Counseling for the Laboratory. Oxford, UK: Oxford University Press; 2017:29–46.
• LaGrave D, Devers Winters PL, Lambert-Messerlian G. Prenatal screening technologies and test issues. In: McKinsey L, Goodenberger BC, Kruisselbrink T, Kruisselbrink T, eds. Practical Genetic Counseling for the Laboratory. Oxford, UK:Oxford University Press; 2017:177–206.